¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå º¸°í¼­(2025³â)
Neuroendovascular Coil Global Market Report 2025
»óǰÄÚµå : 1693360
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 7.4%ÀÇ CAGR·Î 18¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ½Å°æÇ÷°ü »ç·ÊÀÇ Áö¼ÓÀûÀÎ Áõ°¡, ½Å°æ ÁßÀç ¼­ºñ½ºÀÇ È®´ë, Á¶±â °³ÀÔ¿¡ ´ëÇÑ °ü½É, ¼¼°è ÇコÄɾî ÀÎÇÁ¶óÀÇ ¼ºÀå, ȯÀÚ Áß½É Ä¡·á Æ®·»µå, ¿¬±¸ ºÐ¾ßÀÇ ±¹Á¦ Çù·Â µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Å»Âø½Ä ½Å°æÇ÷°ü³» ÄÚÀÏÀÇ ¹ßÀü, ¾×ü »öÀüÁ¦ »ç¿ë Áõ°¡, »ýü Ȱ¼º ¹× »ýüÈí¼ö¼º ÄÚÀÏÀÇ °³¹ß, ÀÌÁßÃþ ÄÚÀÏ ±â¼úÀÇ ÅëÇÕ, µ¿¸Æ·ù Ä¡·á¸¦ À§ÇÑ À¯·®ºÐ¹è±â¿¡ ´ëÇÑ °ü½É µîÀÌ ÀÖ½À´Ï´Ù.

½Å°æÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æÇ÷°üÁúȯÀº ½Å°æ°è¿¡ °ø±ÞÇÏ´Â Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç, Á¾Á¾ ½Å°æÁõ»ó ¹× ÇÕº´ÁõÀ» À¯¹ßÇÕ´Ï´Ù. ½Å°æÇ÷°ü³» ÄÚÀÏÀº Ç÷°ü¿¡ »ðÀÔÇÏ¿© ºñÁ¤»óÀûÀÎ Ç÷°ü ±¸Á¶¸¦ Â÷´ÜÇϰųª ¾ÈÁ¤È­½ÃÄÑ ÃâÇ÷ ¹× ±âŸ ÇÕº´ÁõÀÇ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á ÀÌ·¯ÇÑ ÁúȯÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù ½º¿þµ§ Á¤ºÎ ±â°üÀÎ ±¹¸³º¸°Çº¹ÁöÀ§¿øÈ¸(Socialstyrelsen)ÀÇ º¸°í¿¡ µû¸£¸é, 2022³â¿¡ ¾à 26,800°ÇÀÇ ³úÁ¹ÁßÀÌ º¸°íµÇ¾ú°í, ¾à 25,100¸íÀÇ È¯ÀÚ°¡ ¹ß»ýÇß´Ù°í ÇÕ´Ï´Ù. ±× ÇØ ³úÁ¹Áß ¹ßº´ÀÚ Áß 12%´Â ´çÀÏ, 23%´Â 28ÀÏ À̳», 34%´Â 1³â À̳»¿¡ »ç¸ÁÇß½À´Ï´Ù. µû¶ó¼­ ½Å°æÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÇコÄɾî ÁöÃâÀÇ Áõ°¡´Â ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇコÄɾî ÁöÃâ¿¡´Â ÀÇ·á¿ëǰ, °øÁߺ¸°Ç Ȱµ¿, °ü¸®ºñ µî ÇコÄÉ¾î ¼­ºñ½º¿¡ ´ëÇÑ ÁöÃâÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î´Â Àα¸ °í·ÉÈ­, ÀÇ·á ±â¼ú ¹ßÀü, ¾àǰºñ »ó½Â, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ÀÇ·áºñ Áõ°¡´Â ½Å°æÇ÷°ü³» ÄÚÀÏ ±â¼úÀÇ ¹ßÀü, ±â¼ú Çõ½ÅÀÇ ÃËÁø, Á¢±Ù¼º Çâ»ó, ³úµ¿¸Æ·ù ¹× Ç÷°ü ÁúȯÀÇ Ä¡·á¿¡¼­ ȯÀÚ °á°ú °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ÇмúÁö *Health Affairs*¿¡ µû¸£¸é 2024³â 6¿ù ¹Ì±¹ÀÇ ±¹¹Î ÀÇ·áºñ´Â 2023³â 4Á¶ 7,993¾ï ´Þ·¯¿¡¼­ 2024³â 5Á¶ 4,488¾ï ´Þ·¯·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ¾à 2,495¾ï ´Þ·¯ÀÇ Áõ°¡¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ÀÇ·áºñ Áõ°¡°¡ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A neuroendovascular coil is a slender wire that is introduced into blood vessels to obstruct or redirect blood flow in the affected area, facilitating clot formation and preventing further complications. This medical device is primarily employed in the treatment of cerebral aneurysms and other vascular abnormalities.

The key product types within the realm of neuroendovascular coils include Guglielmi detachable coils (GDCs) and matrix coils. Guglielmi detachable coils (GDCs) serve as medical devices utilized in endovascular procedures to address cerebral aneurysms. They work by filling the aneurysm with detachable platinum coils, promoting clotting and averting the risk of rupture. These coils find application in various indications, encompassing both ruptured and unruptured aneurysms. Additionally, GDCs are employed for diverse purposes such as tumor surgery and medical teaching, with end users including hospitals, ambulatory surgical centers (ASCs), stroke centers, and other medical facilities.

The neuroendovascular coil market research report is one of a series of new reports from The Business Research Company that provides neuroendovascular coil market statistics, including neuroendovascular coil industry global market size, regional shares, competitors with a neuroendovascular coil market share, detailed neuroendovascular coil market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendovascular coil industry. This neuroendovascular coil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of neurovascular diseases, growing aging population, improved diagnostic technologies, expansion of neurointerventional facilities, awareness and education initiatives, regulatory approvals and standards.

The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continuous rise in neurovascular cases, expansion of neurointerventional services, focus on early intervention, global healthcare infrastructure growth, patient-centric care trends, international collaborations in research. Major trends in the forecast period include advancements in detachable neuroendovascular coils, rise in utilization of liquid embolics, development of bioactive and bioabsorbable coils, integration of dual-layer coil technologies, focus on flow diverters for aneurysm treatment.

The increasing prevalence of neurovascular diseases is expected to drive the growth of the neuroendovascular coil market in the future. Neurovascular diseases affect the blood vessels that supply the nervous system, often leading to neurological symptoms and complications. Neuroendovascular coils are used to treat these diseases by being inserted into blood vessels to block or stabilize abnormal blood vessel structures, thus reducing the risk of bleeding or other complications. For example, in November 2023, a report from the National Board of Health and Welfare (Socialstyrelsen), a Sweden-based government agency, revealed that in 2022, approximately 26,800 strokes were reported, affecting about 25,100 individuals. Of those who suffered a stroke that year, 12% died on the same day, 23% within 28 days, and 34% within one year. Therefore, the rising prevalence of neurovascular diseases is fueling the growth of the neuroendovascular coil market.

The increasing healthcare expenditure is expected to propel the growth of the neuroendovascular coil market moving forward. Healthcare expenditure encompasses spending on healthcare services, including medical goods, public health activities, and administrative costs. Factors driving this growth include an aging population, technological advancements in medicine, rising pharmaceutical costs, and the increasing prevalence of chronic diseases. The rising healthcare expenditure contributes to advancements in neuroendovascular coil technology, promoting innovation, enhancing accessibility, and improving patient outcomes for treating cerebral aneurysms and vascular disorders. For instance, in June 2024, according to *Health Affairs*, a US-based academic journal, national healthcare expenditure in the U.S. is projected to increase from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, reflecting an increase of around $249.5 billion. As a result, the growing healthcare expenditure is driving the growth of the neuroendovascular coil market.

Major companies in the neuroendovascular coil market are directing their efforts towards the development of soft and unique-shaped coils. In neuroendovascular procedures, these coils, such as tetrahedral coils, enhance aneurysm treatment by conforming to vessel anatomy, reducing complications, and improving patient outcomes, particularly in complex cases. For example, in December 2022, Stryker Corporation, a US-based medical technology company specializing in neuroendovascular coils, introduced the Target Tetra Detachable Coil. This innovative coil combines a new tetrahedral shape and softness level, specifically designed to treat small aneurysms. It provides a 2-in-1 feature with a unique tetrahedral shape that ensures stability in wide-necked aneurysms and a soft helical tail. This shape offers strong memory while remaining soft, making it a suitable choice for treating small aneurysms.

In April 2022, Wallaby Medical LLC, a US-based medical device company focusing on developing therapies for vascular disease, completed the acquisition of Phenox GmbH for approximately $543 million. This strategic move is expected to expand Wallaby Medical's stroke treatment and prevention product pipeline, facilitating accelerated global expansion. Phenox GmbH is a Germany-based provider of neuroendovascular coils and related products.

Major companies operating in the neuroendovascular coil market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Cook Group Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Minnetronix Medical Inc., SurModics Inc., Galen Medical Group P.C, Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Allium Medical Solutions Ltd., Shape Memory Medical Inc., InnoCore Pharmaceuticals BV, Wuhan HNC Technology Co. Ltd., Neural Co. Ltd., Three Rivers Medical Inc.

North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroendovascular coil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroendovascular coil market consists of sales of push able coils, framed coils, complex-shaped coils, micro coils, macro coils, guidewires (used in conjunction with coils), and catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroendovascular Coil Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroendovascular coil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neuroendovascular coil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroendovascular coil market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Neuroendovascular Coil Market Characteristics

3. Neuroendovascular Coil Market Trends And Strategies

4. Neuroendovascular Coil Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Neuroendovascular Coil Growth Analysis And Strategic Analysis Framework

6. Neuroendovascular Coil Market Segmentation

7. Neuroendovascular Coil Market Regional And Country Analysis

8. Asia-Pacific Neuroendovascular Coil Market

9. China Neuroendovascular Coil Market

10. India Neuroendovascular Coil Market

11. Japan Neuroendovascular Coil Market

12. Australia Neuroendovascular Coil Market

13. Indonesia Neuroendovascular Coil Market

14. South Korea Neuroendovascular Coil Market

15. Western Europe Neuroendovascular Coil Market

16. UK Neuroendovascular Coil Market

17. Germany Neuroendovascular Coil Market

18. France Neuroendovascular Coil Market

19. Italy Neuroendovascular Coil Market

20. Spain Neuroendovascular Coil Market

21. Eastern Europe Neuroendovascular Coil Market

22. Russia Neuroendovascular Coil Market

23. North America Neuroendovascular Coil Market

24. USA Neuroendovascular Coil Market

25. Canada Neuroendovascular Coil Market

26. South America Neuroendovascular Coil Market

27. Brazil Neuroendovascular Coil Market

28. Middle East Neuroendovascular Coil Market

29. Africa Neuroendovascular Coil Market

30. Neuroendovascular Coil Market Competitive Landscape And Company Profiles

31. Neuroendovascular Coil Market Other Major And Innovative Companies

32. Global Neuroendovascular Coil Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroendovascular Coil Market

34. Recent Developments In The Neuroendovascular Coil Market

35. Neuroendovascular Coil Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â